DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Abraxane (Paclitaxel) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (47)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Abraxane (Paclitaxel) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 47   Next >>

Possible Abraxane side effects in female

Reported by a physician from United States on 2012-08-27

Patient: female

Reactions: Neutropenia, Septic Shock, Renal Failure Acute, Leukopenia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Abraxane
    Dosage: 125 milligram/sq. meter
    Start date: 2012-03-28

Gemcitabine Hydrochloride
    Dosage: 1000 milligram/sq. meter
    Start date: 2012-03-28

Abraxane
    Dosage: 125 milligram/sq. meter
    Start date: 2012-04-04
    End date: 2012-04-10

Gemcitabine Hydrochloride
    Dosage: 1000 milligram/sq. meter
    Start date: 2012-04-04
    End date: 2012-04-10



Possible Abraxane side effects in 72 year old female

Reported by a physician from Germany on 2012-08-10

Patient: 72 year old female, weighing 82.0 kg (180.4 pounds)

Reactions: Embolism

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Capecitabine
    Administration route: Oral
    Start date: 2012-07-11

Abraxane
    Start date: 2012-07-11



Possible Abraxane side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-01

Patient: male

Reactions: Mucosal Inflammation, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Doxorubicin HCL
    Start date: 2012-03-09
    End date: 2012-03-09

Abraxane
    Start date: 2012-03-09
    End date: 2012-03-09



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-05

Patient: female

Reactions: Anaphylactic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27

Patient: female, weighing 85.8 kg (188.8 pounds)

Reactions: Nephrolithiasis, Anaemia, Hyperuricaemia, Pneumonitis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 228 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-03-15

Abraxane
    Dosage: 228 milligram
    Start date: 2012-03-15

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Other drugs received by patient: Neulasta; Neulasta; Allopurinol; Allopurinol; Vancomycin; Tolterodine Tartrate; Lorazepam; Lisinopril; Hydrocodone Bitartrate + Acetaminophen; Vancomycin; Pantoprazole; Heparin; Citalopram Hydrobromide; Celebrex; Zofran; Augmentin '125'; Albumin; Dilaudid; Morphine; Fentanyl; Compazine; Flomax; Pantoprazole; Heparin; Insulin Lispro; Lansoprazole; Potassium Chloride; Zosyn; Azithromycin; Heparin; Desmopressin Acetate; Epinephrine; Lansoprazole; Sodium Bicarbonate; Vecuronium Bromide; Trazodone HCL; Nystatin; Potassium Chloride; Levofloxacin; Calcium Gluconate; Chlorhexidine Gluconate; Nystatin; Zosyn; Acetylcysteine; Lansoprazole; Propofol



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: female, weighing 85.8 kg (188.8 pounds)

Reactions: Nephrolithiasis, Anaemia, Pneumonitis, Hyperuricaemia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 228 milligram
    Start date: 2012-03-15

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-03-15

Gemcitabine
    Dosage: 1820 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Abraxane
    Dosage: 228 milligram
    Start date: 2012-05-10
    End date: 2012-05-24

Other drugs received by patient: Hydrocodone; Allopurinol; Allopurinol; Zosyn; Levofloxacin; Acetylcysteine; Lansoprazole; Lansoprazole; Vecuronium Bromide; Dilaudid; Lorazepam; Citalopram Hydrobromide; Nystatin; Neulasta; Potassium Chloride; Zosyn; Heparin; Heparin; Epinephrine; Morphine; Propofol; Trazodone HCL; Nystatin; Desmopressin Acetate; Vancomycin; Vancomycin; Chlorhexidine Gluconate; Compazine; Zofran; Augmentin '125'; Albumin (Human); Sodium Bicarbonate; Neulasta; Flomax; Whole Blood; Tolterodine Tartrate; Fentanyl; Lisinopril; Pantoprazole; Pantoprazole; Heparin; Calcium Gluconate; Insulin Lispro; Lansoprazole; Celebrex; Potassium Chloride; Azithromycin



Possible Abraxane side effects in male

Reported by a physician from Italy on 2012-05-31

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Abdominal Pain, Intestinal Obstruction, Decreased Appetite

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 209 milligram
    Start date: 2012-03-22
    End date: 2012-04-05

Gemcitabine
    Start date: 2012-03-22
    End date: 2012-04-05

Abraxane
    Dosage: 215 milligram
    Start date: 2012-02-23

Gemcitabine
    Start date: 2012-02-23

Other drugs received by patient: Oxycontin; Ondansetron; Dexamethasone; Lansoprazole



Possible Abraxane side effects in female

Reported by a physician from Japan on 2012-05-29

Patient: female

Reactions: Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Zometa



Possible Abraxane side effects in female

Reported by a physician from Spain on 2012-04-27

Patient: female

Reactions: Mucosal Inflammation, Pancytopenia, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in 59 year old female

Reported by a physician from Japan on 2012-04-19

Patient: 59 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Back Pain, Vomiting, Insomnia, Anaphylactic Shock, Pyrexia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Famostagine-D; Sodium Chloride; Dexamethasone Sodium Phosphate



Possible Abraxane side effects in 56 year old female

Reported by a pharmacist from Canada on 2012-04-18

Patient: 56 year old female, weighing 165.0 kg (363.0 pounds)

Reactions: Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Docusate; Eprex; Zopiclone; Prochlorperazine; Dimenhydrinate; Domperidone; Lorazepam; Sodium Chloride; Acetaminophen; Atacand; Lactulose; Morphine; Pantoprazole; Senna-Mint WAF; Fentanyl-100; TPN



Possible Abraxane side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-12

Patient: male

Reactions: Mucosal Inflammation, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in female

Reported by a physician from Spain on 2012-04-10

Patient: female

Reactions: Mucosal Inflammation, Pancytopenia, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane



Possible Abraxane side effects in male

Reported by a physician from United States on 2012-03-27

Patient: male, weighing 79.4 kg (174.7 pounds)

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 489 milligram
    Start date: 2011-12-16

Carboplatin
    Dosage: 489 milligram
    Start date: 2011-12-16

Abraxane
    Dosage: 489 milligram
    Start date: 2012-02-17
    End date: 2012-03-20

Carboplatin
    Dosage: 84 milligram
    Start date: 2012-02-17

Other drugs received by patient: Oxycodone / Acetaminophen; Ciprofloxacin; Simvastatin; Enoxaparin; Benzocaine - Menthol; Nystatin; Miralax; Nicotine; RBC Transfusion; Neulasta; Ciprofloxacin; Nexium; Guafenesin-Codeine; Albuterol; Platelets; Albuterol Sulfate and Ipratropium Bromide; Budesonide-Formaterol; Lorazepam; Sodium Chloride; Arepitant; Amoxicillin and Clavulanate Potassium; Simvastatin; Ondansetron; Senna; Zoledronoc Acid; Omeprazole; Aspirin; Zolpidem; Lorazepam; Sodium Chloride; Calcium - Vitamin D; Alum / MAG Hydrox-Simethicone; Docusate; Dexamethasone



Possible Abraxane side effects in male

Reported by a physician from United States on 2012-03-12

Patient: male, weighing 79.4 kg (174.7 pounds)

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Start date: 2012-02-17

Abraxane
    Dosage: 489 milligram
    Start date: 2011-12-16

Carboplatin
    Dosage: 489 milligram
    Start date: 2011-12-16

Abraxane
    Dosage: 489 milligram
    Start date: 2012-02-17

Other drugs received by patient: Oxycodone / Acetaminophen; Simvastatin; Zolpidem; Lorazepam; Zoledronic Acid; Albuterol; Ciprofloxacin; Enoxaparin; Nystatin; Ondansetron; Ciprofloxacin; Benzocaine - Menthol; Albuterol Sulfate and Ipratropium Bromide; Alum / MAG Hydrox-Simethicone; Sodium Chloride; Budesonide-Formaterol; Miralax; Calcium - Vitamin D; Arepitant; RBC Transfusion; Aspirin; Platelets; Amoxicillin and Clavulanate Potassium; Simvastatin; Docusate; Nicotine; Omeprazole; Neulasta; Nexium; Guafenesin-Codeine; Senna; Lorazepam; Sodium Chloride; Dexamethasone



Possible Abraxane side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07

Patient: 54 year old female, weighing 68.1 kg (149.7 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 80 milligram/sq. meter
    Start date: 2011-10-13

Carboplatin
    Dosage: 6 dosage forms
    Indication: Breast Cancer
    Start date: 2011-08-11

Doxorubicin HCL
    Dosage: 60 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-11-10

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-11-10

Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-08-11
    End date: 2011-10-06

Neulasta
    Indication: Chemotherapy

Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-08-11



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02

Patient: female, weighing 81.1 kg (178.4 pounds)

Reactions: Arrhythmia Supraventricular, Left Ventricular Dysfunction, Ventricular Arrhythmia, Cardiac Arrest, Sinus Tachycardia, Sinus Bradycardia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-04

Paclitaxel
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-04

Bevacizumab
    Indication: Breast Cancer
    Start date: 2011-03-04

Doxorubicin HCL
    Dosage: 60 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-04

Neulasta
    Dosage: 6 milligram
    Indication: Breast Cancer
    Start date: 2011-03-04

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-04

Other drugs received by patient: Lisinopril; Vitamin B-12; Esomeprazole Sodium; Metoprolol Succinate; Folic Acid; Aspirin; Vitamin B6; Atorvastatin



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-09

Patient: female

Reactions: Nausea, Rash, Hypertension, Asphyxia, Loss of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Trimeton; Dexamethasone Sodium Phosphate; Zantac; Navoban



Possible Abraxane side effects in female

Reported by a physician from Japan on 2012-02-03

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Breast Cancer, Stomatitis, Hepatic Function Abnormal

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 400 milligram
    Indication: Breast Cancer
    Start date: 2011-01-24
    End date: 2011-03-28

Abraxane
    Start date: 2011-06-27
    End date: 2011-07-10

Abraxane
    Dosage: 390 milligram
    Start date: 2011-06-06
    End date: 2011-06-27

Lyrica
    Administration route: Oral
    Start date: 2011-03-07
    End date: 2011-07-10

Other drugs received by patient: Gisha-Jinki-GAN



Possible Abraxane side effects in male

Reported by a physician from United States on 2012-02-01

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Dermatitis Acneiform, Stomatitis, Dehydration, Tachycardia, Enteritis Infectious, Femoral Hernia, Obstructive, Fall

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 400 milligram/sq. meter
    Start date: 2011-06-27
    End date: 2011-08-09

Abraxane
    Dosage: 20 milligram/sq. meter
    Start date: 2011-06-27
    End date: 2011-08-09

Cisplatin
    Dosage: 20 milligram/sq. meter
    Start date: 2011-06-27
    End date: 2011-08-09

Erbitux
    Dosage: 250 milligram/sq. meter
    Start date: 2011-07-05

Other drugs received by patient: Magnesium Sulfate; Potassium Chloride; Lovenox; Lovenox; Triple MIX (Benadryl, Maalox, Lidocaine); Veramyst; Dexamethasone; Regular Insulin; Famotidine; Magnesium Sulfate; Potassium Phosphates; Insulin; Ocean Spray; Phosnak; Klor-CON; Metoprolol Tartrate; Singulair; Ondansetron HCL; Magnesium Sulfate; Actiq; Prochlorperazine Maleate; Qualaquin; 0.9% NS; Potassium Chloride; Astepro; Metoprolol Tartrate; Domeboro; Calcium Gluconate; Famotidine; Magnesium Sulfate; Magnesium Sulfate; Genasal; 0.9% NS; Potassium Phosphates; Potassium Chloride; Magnesium Oxide; Metoprolol Tartrate; Ondansetron HCL; 0.9% NS; 0.9% NS; Morphine Sulfate; Rocephin; Magnesium Sulfate; Potassium Phosphates; Doxycycline; RED Blood Cells; Ativan; Metoprolol Tartrate; Benadryl; Calcium Gluconate; Potassium Chloride



Possible Abraxane side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Diarrhoea, Lymphatic Disorder, Anaemia, Platelet Count Decreased, Febrile Neutropenia, Cardiac Disorder

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Doxorubicin HCL
    Dosage: 10 milligram/sq. meter
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-24

Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-24

Neulasta
    Dosage: 6 milligram
    End date: 2011-08-25

Other drugs received by patient: Metoprolol Tartrate; Famotidine; Guaifenesin; Zolpidem; Cefepime; Fluconazole; Prochlorperazine; Bacitracin; Whole Blood; Benzonatate; Acetaminophen



Possible Abraxane side effects in 44 year old female

Reported by a physician from United States on 2012-01-30

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Type 2 Diabetes Mellitus, Lymphatic Disorder, Anaemia, Pancytopenia, Febrile Neutropenia, Cardiac Disorder, Diarrhoea, Platelet Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Neulasta
    Dosage: 6 milligram
    Indication: Breast Cancer
    End date: 2011-08-25

Abraxane
    Dosage: 80 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Other drugs received by patient: Ambien; Pepcid; Mucinex; Tessalon; Toprol-XL; Bacitracin; Prochlorperazine; Armodafinil; Acetaminophen; Cefepime



Possible Abraxane side effects in 52 year old female

Reported by a physician from United States on 2012-01-13

Patient: 52 year old female

Reactions: Haemoglobin Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-01-01
    End date: 2011-04-21

Bevacizumab
    Indication: Breast Cancer
    Start date: 2011-03-10
    End date: 2011-06-21

Pegfilgrastim
    Dosage: 6 milligram
    Indication: Breast Cancer
    Start date: 2011-01-01
    End date: 2011-04-22

Doxorubicin HCL
    Dosage: 60 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-10
    End date: 2011-04-21

Other drugs received by patient: Cyclophosphamide



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13

Patient: female, weighing 76.0 kg (167.2 pounds)

Reactions: Pneumonia, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 125 milligram/sq. meter
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-02-11
    End date: 2011-04-29

Gemcitabine
    Dosage: 1000 milligram/sq. meter
    Indication: Adenocarcinoma Pancreas
    Start date: 2011-02-11
    End date: 2011-04-29

Other drugs received by patient: Imodium; Prilosec; Acetaminophen; Lomotil; Fentanyl; Multi-Vitamins; Ciprofloxacin; Naprosyn; Prochlorperazine Maleate; Acetaminophen; Imodium; Ativan; Morphine; Ativan; Morphine



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-04

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Haemoglobin Decreased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Herceptin
    Dosage: 240 milligram
    Indication: Breast Cancer Metastatic
    Start date: 2010-10-05
    End date: 2011-01-06

Herceptin
    Start date: 2011-01-27

Abraxane
    Dosage: 300 milligram
    Start date: 2011-01-06
    End date: 2011-01-06

Abraxane
    Start date: 2011-01-27

Abraxane
    Dosage: 300 milligram
    Indication: Breast Cancer Metastatic
    Start date: 2010-10-05
    End date: 2010-12-09

Other drugs received by patient: Methycool; Ferotym; Leucon



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-21

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: White Blood Cell Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abraxane

Other drugs received by patient: Posterisan; Sinseron; Magmitt



Possible Abraxane side effects in female

Reported by a physician from Japan on 2011-12-13

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Breast Cancer, Stomatitis, Hepatic Function Abnormal

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 400 milligram
    Indication: Breast Cancer
    Start date: 2011-01-24
    End date: 2011-03-28

Lyrica
    Administration route: Oral
    Start date: 2011-03-07
    End date: 2011-07-10

Abraxane
    Dosage: 390 milligram
    Start date: 2011-06-06
    End date: 2011-06-27

Other drugs received by patient: Gisha-Jinki-GAN



Possible Abraxane side effects in 44 year old female

Reported by a physician from United States on 2011-12-13

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Diarrhoea, Lymphatic Disorder, Anaemia, Febrile Neutropenia, Platelet Count Decreased, Cardiac Disorder

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Doxorubicin HCL
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Abraxane
    Dosage: 80 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Pegfilgrastim
    Dosage: 6 milligram
    Indication: Breast Cancer
    End date: 2011-08-25

Other drugs received by patient: Cefepime; Pepcid; Diflucan; Bacitracin; Mucinex; Tessalon; Ambien; Toprol-XL; Prochlorperazine; Acetaminophen



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-07

Patient: female, weighing 42.0 kg (92.4 pounds)

Reactions: Breast Cancer Metastatic, Interstitial Lung Disease

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 370 milligram
    Start date: 2011-01-11
    End date: 2011-01-11

Gemcitabine
    Indication: Breast Cancer Metastatic
    Start date: 2010-10-01
    End date: 2010-11-25

Abraxane
    Dosage: 370 milligram
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-07
    End date: 2010-12-07

Other drugs received by patient: Oxygen; Prednisolone; Magmitt; Medroxyprogesterone Acetate; Oxygen; Cefepime; Lansoprazole



Possible Abraxane side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-06

Patient: female, weighing 40.0 kg (88.0 pounds)

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, C-Reactive Protein Increased, Sepsis, Neutrophil Count Decreased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abraxane
    Dosage: 350 milligram
    Start date: 2010-10-15
    End date: 2010-10-15

Abraxane
    Dosage: 280 milligram
    Start date: 2010-11-19
    End date: 2010-11-19

Other drugs received by patient: Meropenem; Polygam S / D; Herceptin; Tykerb



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017